These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3774839)

  • 21. Influence of ovarian steroid hormones or platelet-activating factor on mRNA of platelet-activating factor receptor in endometrial explant perfusion cultures from ovariectomized bovine.
    Tiemann U; Bücher K; Pfarrer Ch; Pöhland R; Becker F; Kanitz W; Schmidt P
    Prostaglandins Other Lipid Mediat; 2005 May; 76(1-4):35-47. PubMed ID: 15967160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms of interaction of a plasmalogenic analog of platelet-activating factor with human platelets.
    Kulikov VI; Muzya GI
    Biochemistry (Mosc); 1999 Jun; 64(6):631-5. PubMed ID: 10395976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paf-acether (platelet-activating factor).
    Benveniste J
    Bull Eur Physiopathol Respir; 1986; 22 Suppl 7():91-4. PubMed ID: 3955269
    [No Abstract]   [Full Text] [Related]  

  • 24. Prostaglandins, leukotrienes and PAF selectively modulate lymphocyte subset and eosinophil infiltration into the airways in a murine model of asthma.
    Landgraf RG; Nossi DF; Sirois P; Jancar S
    Prostaglandins Leukot Essent Fatty Acids; 2007; 77(3-4):163-72. PubMed ID: 17923399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of platelet-activating factor (PAF) and its antagonists on the male reproduction].
    Yu SQ
    Sheng Li Ke Xue Jin Zhan; 1995 Jan; 26(1):61-4. PubMed ID: 7604226
    [No Abstract]   [Full Text] [Related]  

  • 26. [Platelet activating factor (PAF) and kidney failure progression].
    Camici M; Carpi A; Sagripanti A
    Minerva Med; 1997 Sep; 88(9):329-34. PubMed ID: 9411309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet activating factor and its role in trauma, shock, and sepsis.
    Ayala A; Chaudry IH
    New Horiz; 1996 May; 4(2):265-75. PubMed ID: 8774801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet-activating factor and bacteremia-induced pulmonary hypertension.
    Clavijo LC; Carter MB; Matheson PJ; Wills-Frank LA; Wilson MA; Wead WB; Garrison RN
    J Surg Res; 2000 Feb; 88(2):173-80. PubMed ID: 10644485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The roles of prostanoids, leukotrienes, and platelet-activating factor in bone metabolism and disease.
    Hikiji H; Takato T; Shimizu T; Ishii S
    Prog Lipid Res; 2008 Mar; 47(2):107-26. PubMed ID: 18187046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells.
    Ma X; Ottino P; Bazan HE; Bazan NG
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2915-21. PubMed ID: 15326102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Augmentation of tumor metastasis by platelet-activating factor.
    Im SY; Ko HM; Kim JW; Lee HK; Ha TY; Lee HB; Oh SJ; Bai S; Chung KC; Lee YB; Kang HS; Chun SB
    Cancer Res; 1996 Jun; 56(11):2662-5. PubMed ID: 8653713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet-activating factor is a mediator in tumor necrosis factor/galactosamine-induced lethality.
    Libert C; Van Molle W; Brouckaert P; Fiers W
    J Inflamm; 1995-1996; 46(3):139-43. PubMed ID: 8844494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet-activating factor: a putative neuromodulator and mediator in the pathophysiology of brain injury.
    Yue TL; Feuerstein GZ
    Crit Rev Neurobiol; 1994; 8(1-2):11-24. PubMed ID: 7907280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for a direct effect on vascular permeability of platelet-activating factor induced hemoconcentration in the guinea pig.
    Handley DA; Lee ML; Saunders RN
    Thromb Haemost; 1985 Dec; 54(4):756-9. PubMed ID: 4089809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Involvement of platelet activating factors in pathologic leukocyte-endothelium interactions in the liver after hemorrhagic shock].
    Marzi I; Bauer M; Reisdorf E; Walcher F
    Zentralbl Chir; 1994; 119(11):814-21. PubMed ID: 7846961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phospholipids, particularly platelet-activating factor (PAF-acether), in experimental bronchoconstriction.
    Vargaftig BB
    Agents Actions Suppl; 1983; 13():155-71. PubMed ID: 6575594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Platelet activating factor--role in regulating the functional activity of the mononuclear phagocyte system].
    Shebzukhov IuV; Mysiakin EB
    Vopr Med Khim; 1996; 42(4):278-83. PubMed ID: 9254510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An update on PAF.
    Spencer DA
    Clin Exp Allergy; 1992 May; 22(5):521-4. PubMed ID: 1628249
    [No Abstract]   [Full Text] [Related]  

  • 39. Abstracts of the meeting: The role of platelet-activating factors in the immune response. Paris, France, June 25 and 26, 1987.
    Prostaglandins; 1987 Aug; 34(2):142-99. PubMed ID: 3671731
    [No Abstract]   [Full Text] [Related]  

  • 40. PAF symposium on allergic, respiratory and cardiovascular diseases, Tokyo, 13-15 February 1991. Selected papers--symposium proceedings.
    J Lipid Mediat; 1992; 5(2):101-201. PubMed ID: 1525348
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.